Top

Pathology & Oncology Research

Published in:

01-12-2006 | Methods

Protocol modifications influence the result of EGF receptor immunodetection by EGFR pharmDx^™ in paraffin-embedded cancer tissues

Authors: Katalin Derecskei, Judit Moldvay, Krisztina Bogos, József Tímár, MD, PhD, DSc

Published in: Pathology & Oncology Research | Issue 4/2006

Title: Protocol modifications influence the result of EGF receptor immunodetection by EGFR pharmDx™ in paraffin-embedded cancer tissues
Authors: Katalin Derecskei
Judit Moldvay
Krisztina Bogos
József Tímár, MD, PhD, DSc
Publication date: 01-12-2006
Publisher: Springer Netherlands
Published in: Pathology & Oncology Research / Issue 4/2006
Print ISSN: 1219-4956
Electronic ISSN: 1532-2807
DOI: https://doi.org/10.1007/BF02893421

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 4/2006

Malignant pilomatricoma in the parietal area

Significance of oral Candida infections in children with cancer

Clinical findings and HER-2/neu gene amplification status of breast carcinoma patients

Estrogen receptor α-negative and progesterone receptor-positive breast cancer: Lab error or real entity?

Subcutaneous metastasis of peritoneal mesothelioma diagnosed by Fine-Needle Aspiration

Lithium suppresses epidermal SERCA2 and PMR1 levels in the rat

Keynote webinar | Spotlight on antibody–drug conjugates in cancer